SMILES,Name,Conditions,NCT_Number,Phases,Unapproval Probability,Approval Probability
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,_LEUPROLIDE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.15308706121537022,0.8469129387846298
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,_ESTRADIOL,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.046079112531195,0.9539208874688048
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,_ESTRADIOL,SCHIZOPHRENIA|SCHIZOAFFECTIVE DISORDER|SCHIZOPHRENIFORM DISORDERS,NCT04093518,Phase 3,0.026361247457709226,0.9736387525422906
CC(=O)[O-],_ACETATE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.13339998908197745,0.8666000109180229
CC(=O)[O-],_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.22973615536626354,0.7702638446337363
CC(=O)[O-],_ACETATE,BURN,NCT01413620,Phase 1,0.21075182543946547,0.7892481745605344
CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,_LEUPROLIDE_ACETATE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.4404531220456188,0.5595468779543813
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,OVARIAN CANCER,NCT04460807,Phase 3,0.11314375938464677,0.8868562406153534
CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,_GOSERELIN,BREAST NEOPLASM,NCT01723774,Phase 2,0.17222586764610656,0.8277741323538937
C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,_FULVESTRANT,NEOPLASMS,NCT02530411,Phase 2,0.2517152178412876,0.7482847821587125
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,_LETROZOLE,OVARIAN CANCER,NCT03378297,Early Phase 1,0.07194548201850763,0.9280545179814924
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.07868363802469681,0.9213163619753032
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.006753322685839131,0.9932466773141608
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,FRONTOTEMPORAL DEMENTIA,NCT04408625,Phase 1|Phase 2,0.19990830586630706,0.8000916941336931
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,"COLITIS, ULCERATIVE",NCT02910245,Phase 3,0.006753322685839131,0.9932466773141608
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,_ABIRATERONE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.1856437423866565,0.8143562576133436
CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,_FLUTAMIDE,PCOS,NCT00930228,Phase 1,0.4300329373172254,0.5699670626827745
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASMS,NCT03693612,Phase 2,0.2604588515415911,0.7395411484584087
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.2831099681652978,0.7168900318347022
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.14654854113550245,0.8534514588644976
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,GASTRIC CANCER,NCT04178460,Phase 1,0.28418993447759583,0.715810065522404
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PROSTATE CANCER,NCT04194554,Phase 1|Phase 2,0.3835188140468963,0.6164811859531039
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,BREAST CANCER,NCT02826512,Phase 2,0.3049090157457934,0.6950909842542068
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PANCREATIC CANCER,NCT03601923,Phase 2,0.38253326614461497,0.6174667338553852
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,PROSTATIC NEOPLASMS,NCT03834519,Phase 3,0.35405550187616464,0.6459444981238355
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,OVARIAN CANCER,NCT03464201,Phase 2,0.36444113025933134,0.6355588697406689
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,BREAST CANCER,NCT02955394,Phase 2,0.3290064915210762,0.6709935084789239
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.14965328560839022,0.8503467143916097
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,NEOPLASMS,NCT03967223,Phase 2,0.1385265691377392,0.861473430862261
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.04678281095005137,0.9532171890499486
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PROSTATE CANCER,NCT03089203,Phase 1,0.2173702001751576,0.7826297998248424
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PANCREATIC CANCER,NCT04390399,Phase 2,0.1715807714907915,0.8284192285092088
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,LIVER TRANSPLANT,NCT03577431,Phase 1|Phase 2,0.2840106964197281,0.7159893035802719
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEPATOCELLULAR CARCINOMA,NCT04011033,Phase 2|Phase 3,0.03678716593077112,0.9632128340692288
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.2761810150084283,0.7238189849915717
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,BREAST CANCER,NCT02897700,Phase 1,0.06826254698135263,0.9317374530186474
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,LYMPHEDEMA,NCT04390685,Phase 1|Phase 2,0.011845006877329041,0.988154993122671
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.6303160684735076,0.36968393152649226
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,NEOPLASMS,NCT03967223,Phase 2,0.5569030802138087,0.4430969197861911
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEPATOCELLULAR CARCINOMA,NCT02905188,Phase 1,0.9821026930674596,0.01789730693254012
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.059689431217164975,0.9403105687828348
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,METASTATIC COLORECTAL CANCER,NCT03869892,Phase 3,0.12866864837293054,0.8713313516270693
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,RECTAL CANCER,NCT01716949,Phase 1|Phase 2,0.03481436397274736,0.9651856360272526
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.05433923177362324,0.9456607682263768
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,STOMACH NEOPLASMS,NCT03675737,Phase 3,0.16348232304846164,0.8365176769515382
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,COLORECTAL CANCER METASTATIC,NCT04245865,Phase 2,0.059689431217164975,0.9403105687828348
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,COLON CANCER,NCT01918527,Phase 3,0.057542431802946374,0.9424575681970536
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,SOFT TISSUE SARCOMA,NCT03114527,Phase 2,0.12678858943202653,0.8732114105679736
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,LIVER TRANSPLANT,NCT03577431,Phase 1|Phase 2,0.2911492848093987,0.7088507151906015
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,END STAGE RENAL DISEASE,NCT03413722,,0.25148576473327217,0.748514235266728
CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,_RIBOCICLIB,BREAST NEOPLASM,NCT03283384,Phase 2,0.3053540615439683,0.6946459384560317
CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,_RIBOCICLIB,SOFT TISSUE SARCOMA,NCT03114527,Phase 2,0.3221294462298849,0.6778705537701153
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.4625398487308808,0.5374601512691193
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,ADVANCED PANCREATIC CANCER,NCT04098081,Phase 2,0.35120056529000365,0.6487994347099968
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASMS,NCT03693612,Phase 2,0.213995305414698,0.7860046945853021
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,GASTRIC CANCER,NCT03801668,Phase 3,0.11707613043512853,0.8829238695648717
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,PANCREATIC CANCER,NCT04054362,Phase 2,0.09460904163829643,0.9053909583617038
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,GASTROINTESTINAL STROMAL TUMORS,NCT03944304,Phase 2,0.0756371008440597,0.9243628991559404
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,_EPIRUBICIN,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.1848821265364543,0.8151178734635458
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,_ENTINOSTAT,BREAST NEOPLASM,NCT03280563,Phase 1|Phase 2,0.3789818468301404,0.6210181531698598
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,_ENTINOSTAT,MYELODYSPLASTIC SYNDROME,NCT02936752,Phase 1,0.7762004392497461,0.2237995607502539
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,_ENTINOSTAT,NEUROENDOCRINE TUMORS,NCT03211988,Phase 2,0.7749825881080992,0.22501741189190105
NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,_VASOPRESSIN,HYPERTENSION,NCT04170751,Not Applicable,0.1292815928342027,0.8707184071657973
N=C(N)NCCC[C@H](N)C(=O)O,_ARGININE,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.4228031512144302,0.5771968487855699
N=C(N)NCCC[C@H](N)C(=O)O,_ARGININE,GASTRIC CANCER,NCT01704664,Not Applicable,0.1422584575551337,0.8577415424448662
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.028406241339527225,0.9715937586604728
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,FRONTOTEMPORAL DEMENTIA,NCT04408625,Phase 1|Phase 2,0.2743292987239542,0.7256707012760458
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,PNEUMONIA,NCT03852537,Phase 2,0.11462479275522,0.8853752072447801
NC[C@H](O)c1ccc(O)c(O)c1,_NOREPINEPHRINE,HYPERTENSION,NCT04170751,Not Applicable,0.08896023515251454,0.9110397648474854
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,PANCREATIC CANCER,NCT04048278,Early Phase 1,0.02413257830092129,0.9758674216990788
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,HEMORRHOID,NCT03797703,Phase 1,0.02413257830092129,0.9758674216990788
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,POMPE DISEASE,NCT02240407,Phase 1,0.0599863569749358,0.9400136430250644
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,"PAIN, CHRONIC",NCT02983682,Phase 3,0.1701594958505028,0.8298405041494971
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,CONTRACEPTION,NCT02799641,Not Applicable,0.02413257830092129,0.9758674216990788
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,ULCERATIVE COLITIS,NCT03759041,Phase 2,0.18142296036533195,0.8185770396346679
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,OSTEOARTHRITIS,NCT04075526,Not Applicable,0.007544576316182156,0.9924554236838178
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS,NCT03685747,Phase 1,0.10802955628656508,0.8919704437134348
CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,_TEICOPLANIN,CYSTIC FIBROSIS,NCT04176328,Phase 1,0.3568359940221167,0.6431640059778836
CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O,_PIPERACILLIN,APPENDICITIS,NCT02991937,Not Applicable,0.08721131600458877,0.9127886839954112
CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1,_GENTAMICIN,ABDOMINAL ABSCESS,NCT03476941,Phase 2,0.21012587095727736,0.7898741290427226
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.017001238496471883,0.9829987615035282
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,BREAST CANCER,NCT01646034,Phase 3,0.1965631829100544,0.8034368170899456
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.9111448294697656,0.08885517053023456
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,FRONTOTEMPORAL DEMENTIA,NCT04408625,Phase 1|Phase 2,0.2178054529861123,0.7821945470138878
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,BETA-THALASSEMIA,NCT03877809,Phase 2,0.12796829467620538,0.8720317053237947
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,ISCHEMIC HEART DISEASE,NCT03600961,,0.1913352327382013,0.8086647672617988
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.9675146917503472,0.03248530824965252
COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,_VERAPAMIL,ISCHEMIC STROKE,NCT03347786,Phase 1,0.3348624757942037,0.6651375242057963
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.2384636540501609,0.7615363459498393
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,PANCREATIC CANCER,NCT04390399,Phase 2,0.2707815663430196,0.7292184336569807
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,RECTAL CANCER,NCT03000374,Phase 2,0.1141334899626976,0.8858665100373027
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,COLORECTAL CANCER METASTATIC,NCT03164655,Phase 2,0.2384636540501609,0.7615363459498393
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,DEPRESSION,NCT02837432,Early Phase 1,0.14576878027048387,0.8542312197295163
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,PROSTATE CANCER,NCT00859781,Phase 2,0.16843494827030994,0.8315650517296903
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,SEPSIS,NCT04160676,Not Applicable,0.01776488015611199,0.982235119843888
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,HIV INFECTION,NCT03237689,Early Phase 1,0.18768124176661294,0.8123187582333873
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISOLONE,PROSTATIC NEOPLASMS,NCT04034095,,0.08757862886270662,0.9124213711372936
S=c1nc[nH]c2nc[nH]c12,_MERCAPTOPURINE,"COLITIS, ULCERATIVE",NCT02910245,Phase 3,0.1314677414642706,0.8685322585357295
Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Ca+2],_LEUCOVORIN_CALCIUM,METASTATIC COLORECTAL CANCER,NCT04097444,Phase 2,0.2581379206612089,0.7418620793387909
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,PROSTATE CANCER,NCT03513211,Phase 1|Phase 2,0.04209366053474538,0.9579063394652546
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,GASTROINTESTINAL CANCER,NCT04214418,Phase 1|Phase 2,0.1729639045266742,0.8270360954733259
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,TYPE 1 DIABETES,NCT03428945,Phase 2,0.07177047749824406,0.9282295225017559
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,POMPE DISEASE,NCT02240407,Phase 1,0.04374983076225242,0.9562501692377476
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,ANALGESIA,NCT03955211,Phase 2,0.19999066269165552,0.8000093373083446
CN(C)CCOC(c1ccccc1)c1ccccc1,_DIPHENHYDRAMINE,POMPE DISEASE,NCT02240407,Phase 1,0.23005490079526775,0.7699450992047325
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O,_OCTREOTIDE,GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR,NCT03972488,Phase 3,0.15115469562182848,0.8488453043781716
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,METASTATIC COLORECTAL CANCER,NCT03626922,Phase 1,0.0753104796622536,0.9246895203377464
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,DIABETIC FOOT,NCT03871049,Not Applicable,0.008500150914217403,0.9914998490857826
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,PERIPHERAL ARTERIAL DISEASE,NCT03942601,Phase 2,0.082889078947154,0.9171109210528458
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,_DEXTROSE,HYSTERECTOMY,NCT03719755,Not Applicable,0.2286320880004,0.7713679119996002
C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,_SOMATOSTATIN,HEPATOCELLULAR CARCINOMA,NCT02799212,Phase 3,0.023657736284042424,0.9763422637159578
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,_CABERGOLINE,ENDOMETRIOSIS,NCT03928288,Phase 2,0.1737621042525307,0.8262378957474694
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,GASTRIC CANCER,NCT04005365,Phase 2,0.16645067287884213,0.8335493271211579
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,COLORECTAL NEOPLASMS,NCT03919461,Phase 2,0.00014128241864272954,0.9998587175813572
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,OBSTRUCTIVE SLEEP APNEA,NCT03049306,Phase 2,0.1428891094513275,0.8571108905486724
Clc1cccc(Cl)c1NC1=NCCN1,_CLONIDINE,CRITICAL ILLNESS,NCT03653832,Phase 3,0.11793309908863653,0.8820669009113634
CC12CC3CC(C)(C1)CC(N)(C3)C2,_MEMANTINE,CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY,NCT03709888,,0.19329502803174356,0.8067049719682565
CC12CC3CC(C)(C1)CC(N)(C3)C2,_MEMANTINE,COGNITION DISORDERS,NCT03342443,Phase 2|Phase 3,0.03873574273380738,0.9612642572661926
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,OBSTRUCTIVE SLEEP APNEA,NCT02484300,Not Applicable,0.16956107833114306,0.8304389216688571
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,IRRITABLE BOWEL SYNDROME,NCT04193501,Phase 3,0.01824336330654936,0.9817566366934508
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,OSTEOPENIA,NCT04233112,Early Phase 1,0.1982558550481737,0.8017441449518263
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MIGRAINE DISORDERS,NCT03597529,Phase 2,0.08093705194931712,0.919062948050683
CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,_SERTRALINE,MYELODYSPLASTIC SYNDROME,NCT02452983,Phase 1,0.3127685069713108,0.6872314930286894
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,METASTATIC COLORECTAL CANCER,NCT03626922,Phase 1,0.2564854266279524,0.743514573372048
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,DELIRIUM,NCT04456985,Not Applicable,0.02415578684822913,0.9758442131517708
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,ANEMIA,NCT04404751,Not Applicable,0.052165443714113136,0.9478345562858868
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,MUCOSITIS,NCT03581773,Phase 2,0.01921758090015714,0.9807824190998428
O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12,_BIOTIN,AMYOTROPHIC LATERAL SCLEROSIS,NCT03427086,Phase 2,0.18052685782267555,0.8194731421773247
O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12,_BIOTIN,ANEMIA,NCT02757898,Phase 1,0.5451428220310156,0.4548571779689843
C[N+](C)(C)CCO,_CHOLINE,GESTATIONAL DIABETES,NCT04302168,Not Applicable,0.6171705118541521,0.3828294881458481
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,OVARIAN CANCER,NCT03924882,Phase 2,0.3601800621570089,0.6398199378429912
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,SOFT TISSUE SARCOMA,NCT03890068,Phase 2,0.4124834829598301,0.58751651704017
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,HEPATOCELLULAR CARCINOMA,NCT03945799,Phase 1|Phase 2,0.38739736472349934,0.6126026352765007
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,GASTROINTESTINAL STROMAL TUMORS,NCT04106024,Phase 2,0.3859433905335347,0.6140566094664653
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,"CARCINOMA, HEPATOCELLULAR",NCT04066543,Phase 2,0.2491693040978605,0.7508306959021396
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,BURN,NCT00985205,Phase 3,0.15616860234745605,0.8438313976525436
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,GASTRIC CANCER,NCT01704664,Not Applicable,0.07008773807781163,0.9299122619221882
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,BURN,NCT00985205,Phase 3,0.15616860234745605,0.8438313976525436
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,GASTRIC CANCER,NCT01704664,Not Applicable,0.07008773807781163,0.9299122619221882
CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,_AMLODIPINE,HYPERTENSION|DYSLIPIDEMIAS,NCT04074551,Phase 3,0.0040401337792642135,0.9959598662207358
CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,_AMLODIPINE,"OBESITY, MORBID",NCT02904291,,0.10596026406978526,0.8940397359302148
CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC,_PERINDOPRIL,ALZHEIMER DISEASE,NCT02085265,Phase 2,0.02222305960910693,0.9777769403908932
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,SEPSIS,NCT04160676,Not Applicable,0.04093216426597328,0.9590678357340268
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,COLORECTAL NEOPLASMS,NCT02969681,Phase 3,0.046026014751485086,0.9539739852485148
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,_THIAMINE,SEPSIS,NCT04160676,Not Applicable,0.04772475765946492,0.9522752423405352
Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1,_THIAMINE,DELIRIUM,NCT04214106,,0.16779462738205608,0.832205372617944
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,_AZACITIDINE,PANCREATIC CANCER,NCT01845805,Phase 2,0.4718401647622722,0.5281598352377279
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,_AZACITIDINE,HEAD AND NECK CANCER,NCT03019003,Phase 1|Phase 2,0.7993596382153896,0.20064036178460995
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,METASTATIC COLORECTAL CANCER,NCT03832621,Phase 2,0.6463419386270531,0.3536580613729465
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,COLORECTAL CANCER,NCT04166435,Phase 2,0.7749495963793486,0.22505040362065107
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,BREAST CANCER,NCT02790580,Phase 2,0.06839259401462862,0.9316074059853712
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,STOMACH NEOPLASMS,NCT03170180,Phase 2,0.06147484565664255,0.9385251543433571
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,GASTROINTESTINAL STROMAL TUMORS,NCT03673501,Phase 3,0.17735094895578496,0.8226490510442149
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,PANCREATIC NEUROENDOCRINE TUMORS,NCT02282059,,0.16870054088829595,0.8312994591117041
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_TEMSIROLIMUS,PERIPHERAL ARTERIAL DISEASE,NCT03942601,Phase 2,0.7127800627699031,0.2872199372300968
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,MALARIA,NCT04456634,Phase 1,0.470397856454694,0.5296021435453062
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,GASTRIC CANCER,NCT04358341,Phase 2,0.06088117303105284,0.9391188269689472
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,_DOXORUBICIN_HYDROCHLORIDE,OVARIAN CANCER,NCT04337632,Phase 3,0.3084526041895003,0.6915473958105
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,"OBESITY, MORBID",NCT03440190,,0.2113575077200759,0.788642492279924
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,LIVER CIRRHOSIS,NCT02642874,Phase 3,0.0067740271566759155,0.9932259728433241
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,OSTEOPOROSIS,NCT04550078,Not Applicable,0.0564141624753764,0.9435858375246235
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O,_CALCIFEDIOL,MYOCARDIAL INFARCTION,NCT02548364,Phase 3,0.00817875979142888,0.9918212402085712
CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,_LUTEIN,PROSTATE CANCER,NCT04136353,Phase 3,0.4089319786082953,0.5910680213917047
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03953261,Phase 2,0.10046426818505187,0.8995357318149481
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,PROSTATE CANCER,NCT03769766,Phase 3,0.10046426818505187,0.8995357318149481
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,BREAST CANCER,NCT03980509,Phase 1,0.3999745183399246,0.6000254816600755
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,ULCERATIVE COLITIS,NCT02277223,Phase 3,0.01898447548454041,0.9810155245154596
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,CHRONIC PERIODONTITIS,NCT04355416,Early Phase 1,0.04541715464174759,0.9545828453582524
NCC(=O)O,_GLYCINE,MILD COGNITIVE IMPAIRMENT,NCT03493178,Early Phase 1,0.5420042219910891,0.4579957780089109
CC(=O)N[C@@H](CS)C(=O)O,_ACETYLCYSTEINE,MILD COGNITIVE IMPAIRMENT,NCT03493178,Early Phase 1,0.22766178656520605,0.7723382134347943
CN(CC(=O)O)C(=N)N,_CREATINE,"COLITIS, ULCERATIVE",NCT02463305,Early Phase 1,0.3391658033402263,0.6608341966597737
CN(CC(=O)O)C(=N)N,_CREATINE,PERIPHERAL ARTERIAL DISEASE,NCT04471792,Phase 2,0.3391658033402263,0.6608341966597737
CN(CC(=O)O)C(=N)N,_CREATINE,INTERMITTENT CLAUDICATION,NCT02993874,Not Applicable,0.14710796070344034,0.8528920392965599
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,HIV INFECTION,NCT04425902,Phase 1,0.3314943809251472,0.6685056190748528
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,CROHN'S DISEASE,NCT03358706,Phase 1,0.1277641391934439,0.8722358608065564
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,"PAIN, POSTOPERATIVE",NCT04280263,Not Applicable,0.15254636566469232,0.847453634335308
CC(C)C[C@H](N)C(=O)O,_LEUCINE,DEPRESSION,NCT03557684,Early Phase 1,0.5340637084286946,0.4659362915713053
CC(C)C[C@H](N)C(=O)O,_LEUCINE,"CIRRHOSIS, LIVER",NCT03208868,Not Applicable,0.5609137208159478,0.43908627918405213
Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,_VITAMIN_E,BREAST CANCER,NCT04463459,Not Applicable,0.0511231315950545,0.9488768684049456
CN(C)C(=N)NC(=N)N,_METFORMIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.015853781375498106,0.984146218624502
CN(C)C(=N)NC(=N)N,_METFORMIN,BREAST CANCER,NCT04559308,Phase 2,0.00014128241864272954,0.9998587175813572
CN(C)C(=N)NC(=N)N,_METFORMIN,FAMILIAL ADENOMATOUS POLYPOSIS,NCT01725490,Phase 2,0.004243808185490954,0.995756191814509
CN(C)C(=N)NC(=N)N,_METFORMIN,COLON CANCER,NCT03359681,Phase 2,0.00014128241864272954,0.9998587175813572
CN(C)C(=N)NC(=N)N,_METFORMIN,PREECLAMPSIA,NCT03717701,Not Applicable,0.00014128241864272954,0.9998587175813572
CN(C)C(=N)NC(=N)N,_METFORMIN,RHEUMATOID ARTHRITIS,NCT04068246,Early Phase 1,0.00014128241864272954,0.9998587175813572
CN(C)C(=N)NC(=N)N,_METFORMIN,OBESITY|WEIGHT LOSS,NCT04194424,Not Applicable,0.00014128241864272954,0.9998587175813572
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NEOPLASMS,NCT02964013,Phase 1,0.4214557650865061,0.5785442349134939
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,METASTATIC COLORECTAL CANCER,NCT03626922,Phase 1,0.5869181704343399,0.4130818295656599
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,COLORECTAL CANCER,NCT02588781,Phase 2,0.5429809630695462,0.4570190369304537
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.044967899465719004,0.9550321005342808
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,COLORECTAL CANCER,NCT03957902,Phase 2,0.01653779217561641,0.9834622078243836
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,SEPSIS,NCT01784159,Phase 2,0.004248958636828075,0.995751041363172
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,COLON CANCER,NCT03464305,Phase 3,0.004248958636828075,0.995751041363172
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.02433521341679344,0.9756647865832064
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,CRITICAL ILLNESS,NCT02285751,Phase 2,0.004248958636828075,0.995751041363172
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,OVARIAN CANCER,NCT03378297,Early Phase 1,0.044967899465719004,0.9550321005342808
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,COLORECTAL CANCER,NCT03957902,Phase 2,0.01653779217561641,0.9834622078243836
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,SEPSIS,NCT01784159,Phase 2,0.004248958636828075,0.995751041363172
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,COLON CANCER,NCT03464305,Phase 3,0.004248958636828075,0.995751041363172
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.02433521341679344,0.9756647865832064
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,CRITICAL ILLNESS,NCT02285751,Phase 2,0.004248958636828075,0.995751041363172
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,_MORPHINE,CESAREAN SECTION,NCT03427463,Early Phase 1,0.01376041518451565,0.9862395848154842
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,_MORPHINE,NEUROPATHIC PAIN,NCT01914042,Phase 2,0.002224882585873469,0.9977751174141264
NC(N)=O,_UREA,HELICOBACTER PYLORI INFECTION,NCT04233684,Not Applicable,0.3321827175394892,0.6678172824605114
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,_ICOSAPENT,COLON CANCER,NCT03661047,Phase 2,0.2164539106704884,0.7835460893295121
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,_ICOSAPENT,ALZHEIMER DISEASE,NCT02719327,Phase 2|Phase 3,0.2339456149547984,0.7660543850452021
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,_ICOSAPENT_ETHYL,COLON CANCER,NCT03661047,Phase 2,0.3262558390042536,0.6737441609957466
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,_ICOSAPENT_ETHYL,ALZHEIMER DISEASE,NCT02719327,Phase 2|Phase 3,0.3111322173957465,0.6888677826042534
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,_PENTOXIFYLLINE,SCHIZOPHRENIA,NCT04094207,Phase 1|Phase 2,0.013585705279272713,0.9864142947207272
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,BREAST CANCER,NCT02958852,Phase 2,0.004243808185490954,0.995756191814509
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,DYSLIPIDEMIA|ATHEROSCLEROSIS,NCT02726555,Phase 3,0.0008604295024751594,0.9991395704975248
CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,_VALSARTAN,"OBESITY, MORBID",NCT03535376,,0.1722085903695806,0.8277914096304194
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,_FEXOFENADINE,GASTROESOPHAGEAL REFLUX,NCT03425097,Phase 2,0.15875359712347673,0.8412464028765234
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,_ANGIOTENSIN,PERIPHERAL ARTERIAL DISEASE,NCT03240068,Early Phase 1,0.2073343802630724,0.7926656197369276
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,_ANGIOTENSIN,RHEUMATOID ARTHRITIS,NCT03770702,Phase 3,0.03194138394831432,0.9680586160516856
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,_ANGIOTENSIN,OBESITY|HYPERTENSION,NCT03604289,Early Phase 1,0.2432681006679176,0.7567318993320825
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,_ANGIOTENSIN,OBESITY,NCT03777215,Early Phase 1,0.15378272444439267,0.8462172755556074
CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,_DARUNAVIR,AMYOTROPHIC LATERAL SCLEROSIS,NCT02437110,Phase 1,0.3849360610428101,0.6150639389571899
C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21,_DOLUTEGRAVIR,AMYOTROPHIC LATERAL SCLEROSIS,NCT02437110,Phase 1,0.3875768996883411,0.6124231003116588
O=C(O)CCCC[C@@H]1CCSS1,_LIPOIC_ACID,AMYOTROPHIC LATERAL SCLEROSIS,NCT04518540,Not Applicable,0.02799282374792252,0.9720071762520774
O=C(O)CCCC[C@@H]1CCSS1,_LIPOIC_ACID,"STROKE, ISCHEMIC",NCT04041167,Phase 3,0.03490980575536152,0.9650901942446384
OC[C@@H]1O[C@@](O)(CO)[C@H](O)[C@H]1O,_FRUCTOSE,CHRONIC KIDNEY DISEASE,NCT01407627,Not Applicable,0.1558644531875676,0.8441355468124324
OC[C@@H]1O[C@@](O)(CO)[C@H](O)[C@H]1O,_FRUCTOSE,NONALCOHOLIC FATTY LIVER DISEASE,NCT01930123,Phase 2,0.3417907006696497,0.6582092993303504
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,GASTRIC CANCER,NCT04379596,Phase 2,0.1406773506011345,0.8593226493988655
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,BREAST CANCER,NCT02897700,Phase 1,0.0719360497983577,0.928063950201642
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,RECTAL CANCER,NCT03299660,Phase 2,0.16973630074768398,0.8302636992523162
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,COLORECTAL CANCER METASTATIC,NCT04245865,Phase 2,0.0775522023479861,0.922447797652014
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,GASTRIC CANCER,NCT04358341,Phase 2,0.08597317685973804,0.9140268231402621
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,PANCREATIC CANCER,NCT04390399,Phase 2,0.20653838304884828,0.7934616169511518
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,COLORECTAL CANCER METASTATIC,NCT03164655,Phase 2,0.09465947530343656,0.9053405246965636
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,ADVANCED COLORECTAL CANCER,NCT04337879,Phase 1|Phase 2,0.055824678741248975,0.9441753212587513
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O,_IRINOTECAN_HYDROCHLORIDE,METASTATIC COLORECTAL CANCER,NCT04097444,Phase 2,0.3801135394356532,0.6198864605643468
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,_PRAVASTATIN,HIV INFECTION,NCT04425902,Phase 1,0.2389105791993477,0.7610894208006524
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,_PRAVASTATIN,PREECLAMPSIA,NCT03648970,Phase 2,0.02455424265397791,0.9754457573460222
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,HIV INFECTION,NCT04425902,Phase 1,0.2887067417279052,0.711293258272095
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,"OBESITY, MORBID",NCT03519906,,0.0832728524213093,0.9167271475786906
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,DYSPEPSIA,NCT02621359,Phase 3,0.014569357387804396,0.9854306426121956
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,HIV INFECTION,NCT04425902,Phase 1,0.08544317112159494,0.9145568288784052
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,CROHN'S DISEASE,NCT03358706,Phase 1,0.013991237592290135,0.9860087624077098
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,GASTROESOPHAGEAL REFLUX DISEASE,NCT03367195,Phase 3,0.00999016617835836,0.9900098338216416
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,HIV INFECTION,NCT04425902,Phase 1,0.2954611372521969,0.7045388627478033
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,RHEUMATOID ARTHRITIS,NCT03770923,Phase 3,0.11477386352129786,0.8852261364787022
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,ALZHEIMER DISEASE,NCT03991988,Phase 2,0.12061658599078408,0.8793834140092158
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,PAIN,NCT02793375,Phase 3,0.12109244961619373,0.8789075503838063
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,BREAST CANCER,NCT04172220,Not Applicable,0.003459087980528313,0.9965409120194716
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,HIV INFECTION,NCT04425902,Phase 1,0.1854282979410994,0.8145717020589006
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,CROHN'S DISEASE,NCT03358706,Phase 1,0.09928266728250056,0.9007173327174993
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,"HEPATITIS B, CHRONIC",NCT02952924,Phase 1,0.11922489081288926,0.8807751091871109
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,"CIRRHOSIS, LIVER",NCT03388151,Phase 3,0.003459087980528313,0.9965409120194716
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,FATIGUE,NCT04141696,Phase 1|Phase 2,0.13568632526969115,0.8643136747303087
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,OVARIAN CANCER,NCT03532139,Phase 2,0.1307274039322204,0.8692725960677798
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,HYPERTENSION|DYSLIPIDEMIAS,NCT04074551,Phase 3,0.0018429286421508394,0.9981570713578491
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,RECTAL CANCER,NCT02569645,Phase 2,0.060389886996538376,0.9396101130034616
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,CIRRHOSIS,NCT02968810,Phase 2,0.025351302623644344,0.9746486973763556
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,LIVER CIRRHOSES,NCT03780673,Phase 2|Phase 3,0.02547876767870201,0.974521232321298
O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,_EZETIMIBE,HYPERTENSION|DYSLIPIDEMIAS,NCT04074551,Phase 3,0.005957615603630253,0.9940423843963698
O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,_EZETIMIBE,CHRONIC HEPATITIS C,NCT02971033,Phase 2,0.05123587819656216,0.948764121803438
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,"OBESITY, MORBID",NCT03440177,,0.12732657938394026,0.8726734206160597
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,MYOCARDIAL INFARCTION,NCT03715998,Phase 2,0.021344765986958003,0.978655234013042
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,_CANDESARTAN,"OBESITY, MORBID",NCT03460327,,0.2859976079664368,0.7140023920335632
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,_CANDESARTAN,MILD COGNITIVE IMPAIRMENT,NCT02646982,Phase 2,0.09914226297309588,0.9008577370269042
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,_CANDESARTAN,PERIPHERAL NEUROPATHY,NCT03688633,Phase 2,0.017362536173533717,0.9826374638264664
CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,_TELMISARTAN,ALZHEIMER DISEASE,NCT02085265,Phase 2,0.00633049238043923,0.9936695076195609
CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_IRBESARTAN,"OBESITY, MORBID",NCT03476603,,0.19260694360340186,0.8073930563965983
NCC(CC(=O)O)c1ccc(Cl)cc1,_BACLOFEN,CIRRHOSIS,NCT04509336,Not Applicable,0.06299165950451284,0.9370083404954872
Cc1ccccc1C(OCCN(C)C)c1ccccc1,_ORPHENADRINE,CIRRHOSIS,NCT04509336,Not Applicable,0.07159571584738593,0.928404284152614
CN1CCC[C@H]1c1cccnc1,_NICOTINE,MILD COGNITIVE IMPAIRMENT,NCT02720445,Phase 2,0.12479006110471585,0.8752099388952843
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,_BUPROPION,WILSON DISEASE,NCT04526210,Phase 1,0.1170271832234116,0.8829728167765886
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl,_BUPROPION_HYDROCHLORIDE,WILSON DISEASE,NCT04526210,Phase 1,0.3573447339510191,0.6426552660489812
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,_ESMOLOL,DIABETIC FOOT ULCER,NCT03998436,Phase 3,0.07366649207876176,0.9263335079212384
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,BREAST CANCER,NCT03109990,Not Applicable,0.009180484967038828,0.9908195150329612
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,CRITICAL ILLNESS,NCT03653832,Phase 3,0.011337379208224977,0.9886626207917752
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,ALZHEIMER DISEASE,NCT04205539,Phase 1,0.2580415916984177,0.7419584083015823
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,ANALGESIA,NCT04442906,Not Applicable,0.005039012914157908,0.994960987085842
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,KIDNEY TRANSPLANTATION,NCT03327389,Not Applicable,0.006337379208224976,0.993662620791775
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,_SORAFENIB,"CARCINOMA, HEPATOCELLULAR",NCT02794337,Phase 2|Phase 3,0.03492241972577586,0.965077580274224
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,ANALGESIA,NCT03974932,Phase 3,0.3299777104891113,0.6700222895108885
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,WILSON DISEASE,NCT04526197,Phase 1,0.12234548589905213,0.8776545141009479
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,_IMATINIB,STOMACH NEOPLASMS,NCT03170180,Phase 2,0.1384253803909365,0.8615746196090635
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,PANCREATIC CANCER,NCT03563248,Phase 2,0.03574048125497062,0.9642595187450296
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,HYPERTENSION|DYSLIPIDEMIAS,NCT04074551,Phase 3,0.04404736900777065,0.9559526309922296
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,"OBESITY, MORBID",NCT03519893,,0.11573123988126988,0.8842687601187299
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,_DASATINIB,ALZHEIMER DISEASE,NCT04063124,Phase 1|Phase 2,0.7764862841205437,0.2235137158794563
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,_DASATINIB,CHRONIC KIDNEY DISEASE,NCT02848131,Phase 2,0.537366208585783,0.46263379141421707
O=C(CCCCCCC(=O)Nc1ccccc1)NO,_VORINOSTAT,CROHN'S DISEASE,NCT03167437,Phase 1|Phase 2,0.8107055082044409,0.18929449179555874
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,_COBIMETINIB,GASTROINTESTINAL CANCER,NCT04214418,Phase 1|Phase 2,0.7730839153249208,0.2269160846750791
Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1,_PANOBINOSTAT,HIV INFECTION,NCT02471430,Phase 1|Phase 2,0.4480658230753721,0.5519341769246278
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,GASTRIC CANCER,NCT03627728,Phase 2,0.09732112886460814,0.9026788711353916
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,RECTAL CANCER,NCT02910843,Phase 1,0.20844604249690052,0.7915539575030996
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,"CARCINOMA, HEPATOCELLULAR",NCT03347292,Phase 1,0.24466719758738556,0.7553328024126147
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.34682278131924404,0.6531772186807561
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,METASTATIC COLORECTAL CANCER,NCT03668431,Phase 2,0.7604186879507542,0.2395813120492454
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.3703563259243648,0.6296436740756355
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,METASTATIC COLORECTAL CANCER,NCT03668431,Phase 2,0.6148665657302851,0.38513343426971497
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,BREAST CANCER,NCT03168074,Phase 2,0.2871620171492569,0.7128379828507433
CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,_VENETOCLAX,BREAST CANCER,NCT04298918,Phase 1|Phase 2,0.5019923399300891,0.4980076600699109
CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1,_VENETOCLAX,MYELODYSPLASTIC SYNDROME,NCT02942290,Phase 1,0.5757315417492179,0.424268458250782
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,_NERATINIB,BREAST NEOPLASM,NCT01670877,Phase 2,0.5334555904990214,0.4665444095009786
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,_NERATINIB,METASTATIC COLORECTAL CANCER,NCT03457896,Phase 2,0.5583873817545276,0.44161261824547215
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BREAST NEOPLASM,NCT03280563,Phase 1|Phase 2,0.4356724796746589,0.5643275203253411
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,PROSTATE CANCER,NCT03706365,Phase 2,0.4630416197793708,0.5369583802206291
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BREAST CANCER,NCT04565054,Phase 3,0.3277397568159594,0.6722602431840408
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,BREAST CANCER,NCT04170465,Phase 2,0.08024268821854118,0.9197573117814586
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,COLON CANCER,NCT03359681,Phase 2,0.0694823594666308,0.9305176405333688
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,HEART FAILURE,NCT03331861,Phase 2,0.23356557822570215,0.766434421774298
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,PROSTATE CANCER,NCT02643667,Phase 1|Phase 2,0.5166411981582266,0.4833588018417732
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,BREAST NEOPLASM,NCT03295552,Phase 2,0.5536954569612712,0.4463045430387288
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.05394079001777869,0.9460592099822214
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,INFERTILITY,NCT03824340,Not Applicable,0.0728650387227747,0.9271349612772252
CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,_TOPIRAMATE,SCHIZOPHRENIA,NCT02808533,Not Applicable,0.0991326609643649,0.900867339035635
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,PCOS,NCT04213677,Phase 3,0.004243808185490954,0.995756191814509
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,TYPE 1 DIABETES,NCT03899402,Phase 2|Phase 3,0.0062554999941547215,0.9937445000058454
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,ALZHEIMER DISEASE,NCT03801642,Phase 1|Phase 2,0.0062554999941547215,0.9937445000058454
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,NONALCOHOLIC STEATOHEPATITIS,NCT03723252,Phase 3,0.004243808185490954,0.995756191814509
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,AGING,NCT04401904,Phase 1|Phase 2,0.0062554999941547215,0.9937445000058454
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,_DICLOFENAC,BREAST CANCER,NCT04511832,Not Applicable,0.1600449789899234,0.8399550210100766
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,_BUPRENORPHINE,"OBESITY, MORBID",NCT03460314,,0.16339282247785966,0.8366071775221404
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,_BUPRENORPHINE,MAJOR DEPRESSIVE DISORDER,NCT04116528,Phase 3,0.10141517249850823,0.8985848275014918
COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,_CODEINE,CHRONIC HEART FAILURE,NCT04332536,Not Applicable,0.060948770562937994,0.9390512294370622
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,ANALGESIA,NCT03955211,Phase 2,0.2948925361252349,0.7051074638747653
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,"OBESITY, MORBID",NCT03476577,,0.15606710177258612,0.8439328982274139
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,_TRIMETHOPRIM,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.3525438690712356,0.6474561309287645
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,_CIPROFLOXACIN,PNEUMONIA,NCT03177720,Phase 1,0.004641365882532801,0.9953586341174672
COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,_DILTIAZEM,ANAL FISSURE,NCT04153032,Phase 2,0.06105598409663467,0.9389440159033654
CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,_RITONAVIR,AMYOTROPHIC LATERAL SCLEROSIS,NCT02437110,Phase 1,0.16144930403515734,0.8385506959648426
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,INFECTION,NCT03844776,Not Applicable,0.022447401098379397,0.9775525989016206
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,PERIODONTITIS,NCT03733379,Phase 3,0.0032026094391946185,0.9967973905608054
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,_DEXTROMETHORPHAN,CROHN'S DISEASE,NCT03358706,Phase 1,0.1477195646329915,0.8522804353670087
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,_DEXTROMETHORPHAN,AMYOTROPHIC LATERAL SCLEROSIS,NCT03883581,Phase 1|Phase 2,0.2710915599277068,0.7289084400722934
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,_DEXTROMETHORPHAN,CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY,NCT02271893,Phase 2,0.07047544073515777,0.9295245592648422
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,_WARFARIN,PANCREATIC CANCER,NCT03536208,Early Phase 1,0.416764021859618,0.5832359781403821
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,_WARFARIN,CROHN'S DISEASE,NCT03358706,Phase 1,0.18255944769502605,0.8174405523049739
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,PREECLAMPSIA,NCT03724838,Not Applicable,0.034254975328964016,0.9657450246710358
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,CYSTIC FIBROSIS,NCT04039087,Phase 2|Phase 3,0.046819569275878166,0.9531804307241216
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,MAJOR DEPRESSIVE DISORDER,NCT04344678,Not Applicable,0.034254975328964016,0.9657450246710358
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,_SILDENAFIL_CITRATE,PREECLAMPSIA,NCT03724838,Not Applicable,0.14742341146287313,0.8525765885371267
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O,_SILDENAFIL_CITRATE,MAJOR DEPRESSIVE DISORDER,NCT04344678,Not Applicable,0.14492134299417245,0.8550786570058274
O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,_CILOSTAZOL,MAJOR DEPRESSIVE DISORDER,NCT04069819,Not Applicable,0.014581811611307638,0.9854181883886924
COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,_APIXABAN,"OBESITY, MORBID",NCT03448783,,0.15131168963071992,0.8486883103692802
COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,_ESOMEPRAZOLE,PREECLAMPSIA,NCT03717701,Not Applicable,0.0019090789070640767,0.9980909210929358
CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O,_CALCITONIN,MIGRAINE DISORDERS,NCT04019496,,0.4346597532481869,0.5653402467518132
CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,_PYRIMETHAMINE,MYELODYSPLASTIC SYNDROME,NCT03057990,Phase 1,0.4369560240264581,0.5630439759735419
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_CHLOROQUINE,ATRIAL FIBRILLATION,NCT02932007,Phase 2,0.3082789956400262,0.6917210043599737
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,SCHIZOPHRENIA,NCT04369391,Phase 1,0.2103794543087773,0.7896205456912229
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,DIABETES,NCT01984827,Phase 1,0.2280203141026008,0.7719796858973993
CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_TIGECYCLINE,SPONTANEOUS BACTERIAL PERITONITIS,NCT04208763,Not Applicable,0.14682485406021972,0.8531751459397803
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,PNEUMONIA,NCT03177720,Phase 1,0.05744547773358905,0.9425545222664108
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,SPONTANEOUS BACTERIAL PERITONITIS,NCT04208763,Not Applicable,0.05744547773358905,0.9425545222664108
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,_ROFLUMILAST,ASTHMA,NCT04108377,Phase 1,0.15600499663316114,0.8439950033668389
[Cl-].[Na+],_SODIUM_CHLORIDE,CROHN'S DISEASE,NCT03681067,Phase 1|Phase 2,0.0665249298412474,0.9334750701587524
[Cl-].[Na+],_SODIUM_CHLORIDE,CHRONIC HEPATITIS B,NCT04465890,Phase 2,0.09753820017071696,0.9024617998292829
[Cl-].[Na+],_SODIUM_CHLORIDE,ACUTE PANCREATITIS,NCT03684278,Phase 2,0.06505623906988299,0.9349437609301172
[Cl-].[Na+],_SODIUM_CHLORIDE,HYPONATREMIA,NCT03703713,,0.07576942192394827,0.9242305780760516
Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,_CEFAZOLIN,BREAST NEOPLASM,NCT03742908,Not Applicable,0.024405883029653862,0.975594116970346
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.027378441844220117,0.97262155815578
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,INFECTION,NCT03844776,Not Applicable,0.02571715724313435,0.9742828427568656
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,PERIODONTITIS,NCT03733379,Phase 3,0.005187987715048252,0.9948120122849516
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,LIVER CIRRHOSIS,NCT03005444,Not Applicable,0.05069718911380604,0.949302810886194
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,BARIATRIC SURGERY,NCT03522259,Phase 2,0.11193538097670086,0.8880646190232991
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,_FLUOXETINE,TYPE 1 DIABETES,NCT03228732,Early Phase 1,0.10525967462020372,0.8947403253797964
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,_FLUOXETINE,"OBESITY, MORBID",NCT03476525,,0.14189300842921654,0.8581069915707835
CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,_ESCITALOPRAM,"OBESITY, MORBID",NCT03460379,,0.1825095424538454,0.8174904575461548
NCC1(CC(=O)O)CCCCC1,_GABAPENTIN,"OBESITY, MORBID",NCT03476538,,0.16280859095094655,0.8371914090490535
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,_ERTAPENEM,URINARY TRACT INFECTIONS,NCT03218800,Phase 3,0.01797803240274317,0.9820219675972568
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,_LEVOFLOXACIN,DYSPEPSIA,NCT02621359,Phase 3,0.15160843978460506,0.8483915602153951
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,_LEVOFLOXACIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT02067780,Phase 2,0.03710344818118711,0.9628965518188128
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,_CEFOTAXIME,SPONTANEOUS BACTERIAL PERITONITIS,NCT04168099,Phase 3,0.05597561784426832,0.9440243821557318
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,_LAMIVUDINE,COLORECTAL CANCER METASTATIC,NCT03144804,Phase 2,0.3546639115058254,0.6453360884941748
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,HYPERTENSION,NCT02133872,Phase 1,0.14803685155211674,0.8519631484478832
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.20651614017334985,0.7934838598266503
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,"STROKE, ISCHEMIC",NCT03320018,Phase 2|Phase 3,0.08875099017866224,0.9112490098213376
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,_CAPSAICIN,AMYOTROPHIC LATERAL SCLEROSIS,NCT02962050,,0.3174332384322334,0.6825667615677666
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,_CAPSAICIN,OBESITY|INSULIN RESISTANCE,NCT03859583,Not Applicable,0.1999062227157156,0.8000937772842842
C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O,_CANNABIDIOL,PRADER-WILLI SYNDROME,NCT03458416,Phase 2,0.5932884377395017,0.4067115622604981
Nc1ccc(O)c(C(=O)O)c1,_MESALAZINE,"COLITIS, ULCERATIVE",NCT02910245,Phase 3,0.0020227473816471085,0.997977252618353
Nc1ccc(O)c(C(=O)O)c1,_MESALAMINE,"COLITIS, ULCERATIVE",NCT02910245,Phase 3,0.0020227473816471085,0.997977252618353
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,_NITAZOXANIDE,DYSPEPSIA,NCT02621359,Phase 3,0.2254470317546832,0.774552968245317
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,_NITAZOXANIDE,CHRONIC HEPATITIS B,NCT03905655,Phase 2,0.2245683007362533,0.7754316992637468
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,_NITAZOXANIDE,GASTROENTERITIS,NCT02165813,Phase 2|Phase 3,0.13404380277456698,0.865956197225433
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,_OLANZAPINE,GASTRIC CANCER,NCT03575637,Phase 2,0.06137294163020946,0.9386270583697904
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,AMYOTROPHIC LATERAL SCLEROSIS,NCT03693781,Phase 2,0.05200586658683571,0.9479941334131644
CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,_TERBINAFINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.13901509497482525,0.8609849050251748
CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,_CEPHALEXIN,CYSTIC FIBROSIS,NCT04553419,Phase 3,0.05124096254753343,0.9487590374524664
N[C@@H]1CONC1=O,_CYCLOSERINE,MAJOR DEPRESSIVE DISORDER,NCT03511599,Phase 1,0.2864342355985553,0.7135657644014449
Oc1ncnc2[nH]ncc12,_ALLOPURINOL,CHRONIC KIDNEY DISEASE,NCT03990363,Phase 2,0.055837770768439036,0.944162229231561
c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,_PLERIXAFOR,"DIABETES MELLITUS, TYPE 1",NCT03182426,Phase 1|Phase 2,0.6337620407158543,0.3662379592841456
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,PROSTATE CANCER,NCT02944201,Phase 2,0.28885644990911985,0.7111435500908803
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,BREAST CANCER,NCT03879629,Phase 2,0.07259682150265773,0.927403178497342
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,PANCREATIC CANCER,NCT03434678,Phase 3,0.03650697907427285,0.9634930209257272
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,HEART FAILURE,NCT02421341,Not Applicable,0.03650697907427285,0.9634930209257272
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,ANALGESIA,NCT04442906,Not Applicable,0.004243808185490954,0.995756191814509
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,_ONDANSETRON,RECTAL CANCER,NCT03182179,Not Applicable,0.015253090527013553,0.9847469094729866
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,_ONDANSETRON,CHOLECYSTITIS,NCT04468685,Phase 2,0.01512340452196754,0.9848765954780324
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,_ONDANSETRON,ADVERSE REACTION TO OTHER DRUGS AND MEDICINES,NCT02436798,,0.1594357041105953,0.8405642958894046
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,COLORECTAL CANCER,NCT03273231,Not Applicable,0.013830392174510412,0.9861696078254896
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,FATIGUE,NCT04141696,Phase 1|Phase 2,0.11519145283908518,0.8848085471609148
FCOC(C(F)(F)F)C(F)(F)F,_SEVOFLURANE,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.10137085769711657,0.8986291423028834
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,PANCREATIC CANCER,NCT03434678,Phase 3,0.002583335560961266,0.9974166644390388
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,ANALGESIA,NCT03922048,Phase 2,0.13813916182419653,0.8618608381758037
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,CESAREAN SECTION,NCT03498118,Not Applicable,0.004243808185490954,0.995756191814509
CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl,_LIDOCAINE_HYDROCHLORIDE,PANCREATIC CANCER,NCT04048278,Early Phase 1,0.13418751994765007,0.8658124800523498
CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl,_LIDOCAINE_HYDROCHLORIDE,HEMORRHOID,NCT03797703,Phase 1,0.13418751994765007,0.8658124800523498
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,PANCREATIC CANCER,NCT03434678,Phase 3,0.0276694228316952,0.9723305771683048
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,CRITICAL ILLNESS,NCT03653832,Phase 3,0.009440104974630312,0.9905598950253698
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.0276694228316952,0.9723305771683048
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,"CIRRHOSIS, LIVER",NCT03388151,Phase 3,0.005337579207782089,0.994662420792218
CNCCC=C1c2ccccc2CCc2ccccc21,_NORTRIPTYLINE,FUNCTIONAL DYSPEPSIA,NCT03652571,Phase 3,0.101987261611157,0.8980127383888431
O=S(=O)([O-])[O-].[Mg+2],_MAGNESIUM_SULFATE,POST-ERCP PANCREATITIS,NCT03749590,Phase 3,0.03941223372876078,0.9605877662712392
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,PROLIFERATIVE DIABETIC RETINOPATHY,NCT02447185,Phase 3,0.03551360790367726,0.9644863920963226
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,PSORIASIS,NCT04117919,Phase 2,0.0312697997181863,0.9687302002818136
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_TRIAMCINOLONE_ACETONIDE,PROLIFERATIVE DIABETIC RETINOPATHY,NCT02447185,Phase 3,0.11953162960818048,0.8804683703918195
N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,_GUANFACINE,ALZHEIMER DISEASE,NCT03116126,Phase 3,0.16786293853245093,0.8321370614675488
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,_OXYCODONE,COLORECTAL CANCER,NCT03253133,Phase 1,0.16584147028903215,0.8341585297109678
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,_DIAZEPAM,CONTRACEPTION,NCT02799641,Not Applicable,0.17349457993246775,0.8265054200675321
O=C([O-])O.[Na+],_SODIUM_BICARBONATE,CHRONIC KIDNEY DISEASE,NCT02411773,Phase 2,0.1474135392379752,0.8525864607620247
O=C(O)O,_BICARBONATE,CHRONIC KIDNEY DISEASE,NCT02411773,Phase 2,0.33754984685121897,0.6624501531487816
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,OBESITY,NCT03866408,Early Phase 1,0.004243808185490954,0.995756191814509
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,GASTROPARESIS,NCT04300127,Early Phase 1,0.035550056149616274,0.9644499438503836
Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1,_BLEOMYCIN,GASTRIC CANCER,NCT04139070,Phase 1,0.6038253261672447,0.3961746738327551
O=S(=O)(O)CCS,_MESNA,LIVER TRANSPLANT,NCT03577431,Phase 1|Phase 2,0.8560556920990275,0.14394430790097246
O=S(=O)(O)CCS,_MESNA,CROHN'S DISEASE,NCT00692939,Phase 1|Phase 2,0.9474364702876455,0.052563529712354534
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,PREECLAMPSIA,NCT02221830,Early Phase 1,0.12717685541336507,0.8728231445866349
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,OBESITY,NCT03043053,Phase 2,0.14232311781880644,0.8576768821811934
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,POSTOPERATIVE PAIN,NCT03011307,Phase 2,0.1330793096333155,0.8669206903666844
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,NEUROPATHIC PAIN,NCT02100956,Phase 2,0.17505950789556224,0.8249404921044377
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,PRADER-WILLI SYNDROME,NCT03114371,Not Applicable,0.08719200834965399,0.9128079916503459
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,PROSTATE CANCER,NCT03808077,Phase 2,0.043309196817855486,0.9566908031821444
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,PANCREATIC CANCER,NCT03434678,Phase 3,0.038589525006954915,0.9614104749930452
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,CRITICAL ILLNESS,NCT03791801,Not Applicable,0.03174516811652122,0.9682548318834788
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,_NALBUPHINE,POSTOPERATIVE COMPLICATIONS,NCT03470077,Phase 2,0.03134278910768085,0.9686572108923192
CCN(CC)C(=O)C1(c2ccccc2)CC1CN,_MILNACIPRAN,DEPRESSION,NCT02783430,Phase 2|Phase 3,0.2913280623696099,0.7086719376303902
CCN(CC)C(=O)C1(c2ccccc2)CC1CN,_MILNACIPRAN,NEUROPATHIC PAIN,NCT01914042,Phase 2,0.2913280623696099,0.7086719376303902
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,PAIN,NCT04034004,Early Phase 1,0.09574364307885454,0.9042563569211454
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,"DIABETES MELLITUS, TYPE 1",NCT03149770,Phase 2,0.09574364307885454,0.9042563569211454
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,EPILEPSY,NCT02332447,Phase 3,0.04072492035319658,0.9592750796468036
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,BURN,NCT03513406,Phase 3,0.07805463989435887,0.9219453601056412
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,GASTRIC CANCER,NCT04205097,Not Applicable,0.02196274802857468,0.9780372519714252
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,CRITICAL ILLNESS,NCT03791801,Not Applicable,0.02120655621406563,0.9787934437859344
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,POSTOPERATIVE PAIN,NCT04544228,Not Applicable,0.037287559711818775,0.9627124402881811
CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1,_TENOFOVIR_ALAFENAMIDE,AMYOTROPHIC LATERAL SCLEROSIS,NCT02437110,Phase 1,0.2542928590195982,0.7457071409804018
C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O,_TENOFOVIR,AMYOTROPHIC LATERAL SCLEROSIS,NCT02437110,Phase 1,0.11606728721295308,0.883932712787047
COc1cc(CC(C)N)c(OC)cc1C,_DOM,CHRONIC HEPATITIS B,NCT02287857,Not Applicable,0.17842085555143405,0.8215791444485662
COc1cc(CC(C)N)c(OC)cc1C,_DOM,STROKE,NCT03828851,Not Applicable,0.06837371836041843,0.9316262816395816
COc1cc(CC(C)N)c(OC)cc1C,_DOM,GASTROPARESIS,NCT03810287,Early Phase 1,0.4930078437187841,0.506992156281216
CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,_SOFOSBUVIR,HEPATITIS B INFECTION,NCT03312023,Phase 2,0.047208161165660414,0.9527918388343396
CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,_SOFOSBUVIR,LIVER TRANSPLANT|HEPATITIS C,NCT03819322,Phase 2,0.013304024918833814,0.9866959750811662
COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,_LEDIPASVIR,HEPATITIS B INFECTION,NCT03312023,Phase 2,0.0914492123201803,0.9085507876798198
CS(=O)(=O)O.Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1,_PRADEFOVIR_MESYLATE,CHRONIC HEPATITIS B,NCT04543565,Phase 3,0.3064089828894052,0.6935910171105949
Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1,_PRADEFOVIR,CHRONIC HEPATITIS B,NCT04543565,Phase 3,0.2720908738981599,0.7279091261018402
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,PELVIC ORGAN PROLAPSE,NCT03216083,Phase 3,0.03659372542301212,0.9634062745769876
OCC(O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,_ISOMALT,IRON DEFICIENCY ANEMIA TREATMENT,NCT03610230,Not Applicable,0.08839191076356538,0.9116080892364344
CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,_MISOPROSTOL,CLOSTRIDIUM DIFFICILE,NCT03617172,Phase 2,0.17101472392510644,0.8289852760748936
CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,_MITOMYCIN,COLORECTAL CANCER,NCT02614534,Phase 3,0.7355355058382484,0.2644644941617513
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,_VANDETANIB,NEOPLASMS,NCT02530411,Phase 2,0.6254366192942804,0.3745633807057194
NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,_FAMOTIDINE,EOSINOPHILIC ESOPHAGITIS,NCT04248712,Phase 2,0.04751277740908458,0.9524872225909152
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,_HYDROCHLOROTHIAZIDE,"OBESITY, MORBID",NCT03476551,,0.1648472649034731,0.8351527350965269
[Cl-].[K+],_POTASSIUM_CHLORIDE,HEART FAILURE,NCT02840799,Phase 2,0.10268015956899453,0.8973198404310054
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Mg+2].[Mg+2].[Mg+2],_MAGNESIUM_CITRATE,DIABETIC NEPHROPATHY,NCT03824379,Phase 2,0.04411625945264597,0.955883740547354
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,_BROMOCRIPTINE,OBESITY,NCT03525002,Phase 2,0.195364914947898,0.8046350850521022
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,_GEFITINIB,STOMACH NEOPLASMS,NCT03170180,Phase 2,0.4517009362204684,0.5482990637795316
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,_LAPATINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.9370861485937506,0.06291385140624936
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,_CRIZOTINIB,NEOPLASMS,NCT03194893,Phase 3,0.65917442396524,0.3408255760347598
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,PANCREATIC CANCER,NCT04415385,Phase 2,0.11770995779269995,0.8822900422073001
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,COLORECTAL CANCER,NCT04446091,Phase 1|Phase 2,0.13002214971965526,0.8699778502803447
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.11770995779269995,0.8822900422073001
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,COLORECTAL NEOPLASMS,NCT03743428,Not Applicable,0.14599392240950468,0.8540060775904954
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEAD AND NECK CANCER,NCT03654612,Phase 1|Phase 2,0.11770995779269995,0.8822900422073001
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,PANCREATIC CANCER,NCT04415385,Phase 2,0.11770995779269995,0.8822900422073001
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,COLORECTAL CANCER,NCT04446091,Phase 1|Phase 2,0.13002214971965526,0.8699778502803447
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.11770995779269995,0.8822900422073001
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,COLORECTAL NEOPLASMS,NCT03743428,Not Applicable,0.14599392240950468,0.8540060775904954
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEAD AND NECK CANCER,NCT03654612,Phase 1|Phase 2,0.11770995779269995,0.8822900422073001
C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,_SAVOLITINIB,PROSTATE CANCER,NCT03385655,Phase 2,0.3692657167753491,0.630734283224651
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,OVARIAN CANCER,NCT03763123,Phase 1,0.4636098120213133,0.5363901879786868
CN(C)CCC=C1c2ccccc2CCc2ccccc21,_AMITRIPTYLINE,GERD,NCT04292470,Not Applicable,0.3110266947753259,0.6889733052246744
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,_FLOXURIDINE,COLORECTAL NEOPLASMS,NCT04552093,Phase 2|Phase 3,0.438974212447448,0.5610257875525522
Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,_TALAZOPARIB,BREAST CANCER,NCT04039230,Phase 1|Phase 2,0.7585833524368583,0.24141664756314135
Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,_TALAZOPARIB,PANCREATIC CANCER,NCT03637491,Phase 2,0.6534043799081529,0.34659562009184663
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,END STAGE RENAL DISEASE,NCT03713190,Phase 2,0.012163092864079643,0.9878369071359204
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,TYPE 1 DIABETES,NCT04201496,Phase 1,0.14216857350091314,0.8578314264990867
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,CHRONIC KIDNEY DISEASE,NCT03594110,Phase 3,0.06983853514865411,0.930161464851346
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,GESTATIONAL DIABETES,NCT03215069,Phase 3,0.01162617862077378,0.988373821379226
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,PREDIABETIC STATE|INSULIN RESISTANCE,NCT04131582,Phase 3,0.0005233968804159449,0.9994766031195842
OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,_EMPAGLIFLOZIN,ACUTE DECOMPENSATED HEART FAILURE,NCT04049045,Phase 2,0.005859164855663968,0.9941408351443359
CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1,_ERTUGLIFLOZIN,TYPE 2 DIABETES,NCT04029480,Phase 3,0.2843304965049733,0.715669503495027
CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F,_EVOGLIPTIN,"DIABETES MELLITUS, TYPE 2",NCT04326166,,0.3250030234035878,0.6749969765964124
Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,_MARAVIROC,STROKE,NCT03172026,Phase 2|Phase 3,0.18267866612981887,0.8173213338701812
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_ALBUTEROL,INSULIN RESISTANCE,NCT04558190,Not Applicable,0.06834207397581987,0.93165792602418
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_SALBUTAMOL,INSULIN RESISTANCE,NCT04558190,Not Applicable,0.06834207397581987,0.93165792602418
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,"OBESITY, MORBID",NCT03449472,,0.19590936381472407,0.8040906361852759
O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,_LURASIDONE,BIPOLAR DISORDER,NCT02731612,Phase 3,0.22552293294583314,0.7744770670541667
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,_CLOPIDOGREL,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.017639972208529434,0.9823600277914704
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,_CLOPIDOGREL,CRITICAL ILLNESS,NCT02285751,Phase 2,0.002487592402727714,0.9975124075972722
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,_CLOPIDOGREL,DIABETES MELLITUS TYPE 2,NCT04305587,Phase 1,0.051277030068220535,0.9487229699317794
COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,_RABEPRAZOLE,INFECTIOUS DISEASES,NCT04489797,Phase 1,0.038845102291905576,0.9611548977080944
OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,_LACTOSE,CRITICAL ILLNESS,NCT03464708,Phase 2,0.05002836406559854,0.9499716359344016
CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,_MEGESTROL_ACETATE,BREAST CANCER,NCT03306472,Phase 2,0.09919853003078774,0.9008014699692124
NCCCC[C@H](N)C(=O)O,_LYSINE,HEART FAILURE,NCT03446651,Early Phase 1,0.5742965428271687,0.4257034571728312
C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,_ARTESUNATE,COLORECTAL CANCER,NCT03093129,Phase 2,0.1870246886729122,0.8129753113270879
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1,_PIRARUBICIN,SOFT TISSUE SARCOMA,NCT04126811,Phase 2,0.11002123371541787,0.8899787662845821
CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC1(C)CCc2cc(O)ccc2O1,_TOCOTRIENOL,BREAST CANCER,NCT03855423,Not Applicable,0.4380220880934299,0.5619779119065701
CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC1(C)CCc2cc(O)ccc2O1,_TOCOTRIENOL,COLORECTAL CANCER METASTATIC,NCT04245865,Phase 2,0.4168572822359561,0.5831427177640439
CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC1(C)CCc2cc(O)ccc2O1,_TOCOTRIENOL,AMYOTROPHIC LATERAL SCLEROSIS,NCT04140136,Phase 2,0.4271556343913989,0.5728443656086012
CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC1(C)CCc2cc(O)ccc2O1,_TOCOTRIENOL,ATRIAL FIBRILLATION,NCT03807037,Phase 2|Phase 3,0.4168572822359561,0.5831427177640439
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,_DOBUTAMINE,MYOCARDIAL INFARCTION,NCT03289728,Not Applicable,0.07492473856088039,0.9250752614391198
CN1CCN2c3ncccc3Cc3ccccc3C2C1,_MIRTAZAPINE,BREAST CANCER,NCT02336750,Phase 3,0.039612010650947126,0.9603879893490529
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,_EPLERENONE,HIV INFECTION,NCT02740179,Not Applicable,0.07972281843253902,0.9202771815674612
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,_EPLERENONE,END-STAGE RENAL DISEASE,NCT02490904,Phase 3,0.021700852223295646,0.9782991477767042
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,_FUROSEMIDE,NEPHROTIC SYNDROME,NCT03750136,Not Applicable,0.021132576311365205,0.9788674236886348
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.13049543611844966,0.8695045638815506
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,PELVIC ORGAN PROLAPSE,NCT01648751,Not Applicable,0.18563290474048166,0.8143670952595187
CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,_AXITINIB,GASTROINTESTINAL STROMAL TUMORS,NCT04258956,Phase 2,0.5341230224793334,0.4658769775206666
COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,_TIVOZANIB,HEPATOCELLULAR CARCINOMA,NCT03970616,Phase 1|Phase 2,0.6385776000333012,0.36142239996669856
C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O,_MUPIROCIN,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.3022525582418951,0.6977474417581051
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,BREAST CANCER,NCT02395614,Not Applicable,0.19609333547417326,0.8039066645258268
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,INFECTION,NCT03844776,Not Applicable,0.061089251266803014,0.9389107487331968
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.3032852565899313,0.6967147434100689
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,DIABETIC FOOT ULCER,NCT03503370,Phase 2,0.18676380760710973,0.8132361923928905
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,PERI-IMPLANTITIS,NCT03977324,Not Applicable,0.008197856110012485,0.9918021438899874
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_CHLORHEXIDINE_GLUCONATE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.4071403616738858,0.5928596383261142
Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,_SULFAMETHOXAZOLE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.4478382946798337,0.5521617053201662
C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O,_PARICALCITOL,PANCREATIC CANCER,NCT04054362,Phase 2,0.20881733235485025,0.7911826676451497
Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,_ZOLPIDEM,PROSTATIC NEOPLASMS,NCT03436745,Phase 1,0.20093469564035704,0.799065304359643
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_MANNITOL,DIABETIC PERIPHERAL NEUROPATHY,NCT02728687,Phase 1|Phase 2,0.2269906069420898,0.7730093930579105
O=c1[nH]c(=O)n(C2CCCO2)cc1F,_TEGAFUR,GASTRIC CANCER,NCT03006705,Phase 3,0.1704601899927343,0.8295398100072658
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21,_GALETERONE,ADVANCED PANCREATIC CANCER,NCT04098081,Phase 2,0.2683737430649184,0.7316262569350817
Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,_FOLINIC_ACID,RECTAL CANCER,NCT02704520,Phase 2|Phase 3,0.7634482900100905,0.23655170998990935
Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,_FOLINIC_ACID,COLORECTAL CANCER METASTATIC,NCT03751176,Phase 2,0.7292140914432328,0.270785908556767
Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,_FOLINIC_ACID,ADVANCED COLORECTAL CANCER,NCT04252456,Not Applicable,0.8886867436913808,0.11131325630861884
COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4,_TRABECTEDIN,SOFT TISSUE SARCOMA,NCT02367924,,0.5294530347765011,0.4705469652234989
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_ALDOXORUBICIN,PANCREATIC CANCER,NCT04390399,Phase 2,0.9124521718093468,0.08754782819065328
NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,_EPACADOSTAT,RECTAL CANCER,NCT03516708,Phase 1,0.8029611826836497,0.19703881731635026
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_BETAMETHASONE,GOUT ATTACK,NCT04306653,Not Applicable,0.028222077164284,0.971777922835716
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,_DRONABINOL,ALZHEIMER DISEASE,NCT02792257,Phase 2,0.15421459499139392,0.8457854050086061
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,_DRONABINOL,BIPOLAR DISORDER,NCT04231643,Early Phase 1,0.19209382344572645,0.8079061765542734
Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,_DABIGATRAN,ACUTE PANCREATITIS,NCT03807856,Phase 1,0.1341043504529173,0.8658956495470826
Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,_DABIGATRAN,LIVER CIRRHOSIS|PORTAL VEIN THROMBOSIS,NCT04433481,Not Applicable,0.08275576147633715,0.9172442385236628
NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,_RIBAVIRIN,"HEPATITIS B, CHRONIC",NCT03759782,Phase 3,0.01619481898249311,0.9838051810175068
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,SPONTANEOUS BACTERIAL PERITONITIS,NCT04159870,Phase 3,0.003945456030048175,0.996054543969952
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,LIVER CIRRHOSES,NCT03780673,Phase 2|Phase 3,0.006944558726908214,0.993055441273092
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,TYPE 2 DIABETES,NCT03758144,Not Applicable,0.007849234154943678,0.9921507658450563
CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O,_TADALAFIL,CIRRHOSIS,NCT03566914,Not Applicable,0.04458718107374442,0.9554128189262556
Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,_METOLAZONE,ACUTE HEART FAILURE,NCT04163588,Phase 3,0.3633757420747085,0.6366242579252919
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,_URSODIOL,LIVER DISEASES,NCT02943707,Phase 2,0.06669913076606199,0.933300869233938
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,_URSODEOXYCHOLIC_ACID,LIVER DISEASES,NCT02943707,Phase 2,0.06669913076606199,0.933300869233938
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.15750511841191878,0.8424948815880812
COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,_MEBENDAZOLE,COLORECTAL CANCER,NCT03925662,Phase 3,0.02926695715511504,0.9707330428448848
CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,_RUCAPARIB,BREAST CANCER,NCT03911453,Early Phase 1,0.6090922416353801,0.3909077583646197
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,_ZAFIRLUKAST,OVARIAN CANCER,NCT04339140,Phase 2,0.44378675310145693,0.5562132468985429
FC(F)(F)C(F)(F)C(F)(F)F,_PERFLUTREN,HEPATOCELLULAR CARCINOMA|LIVER CANCER,NCT03199274,Early Phase 1,0.2595948289148366,0.7404051710851636
FS(F)(F)(F)(F)F,_SULFUR_HEXAFLUORIDE,CIRRHOSIS,NCT03407001,Early Phase 1,0.31984283099268634,0.6801571690073138
CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C([C@@H](C)O)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,_COLISTIN,SPONTANEOUS BACTERIAL PERITONITIS,NCT04208763,Not Applicable,0.1381341079067946,0.8618658920932053
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,_TOFACITINIB,PSORIATIC ARTHRITIS,NCT03486457,Phase 3,0.2809134626638313,0.719086537336169
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,BURN,NCT03513406,Phase 3,0.1103325463165154,0.8896674536834847
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,GASTRIC CANCER,NCT04205097,Not Applicable,0.02804035930068552,0.9719596406993144
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,CRITICAL ILLNESS,NCT03791801,Not Applicable,0.03093139207755864,0.9690686079224412
CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,_ETODOLAC,COLORECTAL NEOPLASMS,NCT03919461,Phase 2,0.16587725970961956,0.8341227402903806
OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,_LACTULOSE,CROHN'S DISEASE,NCT03962998,Early Phase 1,0.13022458890264732,0.8697754110973527
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,_ENALAPRIL,"OBESITY, MORBID",NCT03460366,,0.13123650345384308,0.868763496546157
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF,_FLUTICASONE,PHARMACOKINETICS,NCT03739294,Phase 2,0.09083572889101443,0.9091642711089852
[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],_FERUMOXYTOL,CORONARY ARTERY DISEASE,NCT02954510,Phase 3,0.30226076532448265,0.6977392346755177
CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,_SULINDAC,COLORECTAL NEOPLASMS,NCT01349881,Phase 3,0.7969488560298689,0.20305114397013088
NCCCC(N)(C(=O)O)C(F)F,_EFLORNITHINE,COLORECTAL NEOPLASMS,NCT01349881,Phase 3,0.6769669223437705,0.3230330776562289
Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,_BUTORPHANOL,COLONOSCOPY,NCT04477733,Not Applicable,0.05818974220247587,0.941810257797524
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],_NITROGLYCERIN,HYPERTENSION,NCT02425566,Phase 1,0.2985825023427675,0.7014174976572326
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],_NITROGLYCERIN,ACUTE HEART FAILURE,NCT03302910,Phase 2|Phase 3,0.17981468678593993,0.8201853132140604
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03843125,Phase 3,0.3982135173815112,0.6017864826184888
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,PROSTATE CANCER,NCT03716739,Phase 2,0.032048580170778086,0.9679514198292218
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,LIVER CIRRHOSIS,NCT03995251,Not Applicable,0.0011401066490491249,0.9988598933509508
CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,_TESTOSTERONE_ENANTHATE,PROSTATE CANCER,NCT02090114,Phase 2,0.37057335942736747,0.6294266405726328
O=C(O)c1cccnc1,_NIACIN,TYPE 2 DIABETES MELLITUS|OBESITY,NCT03867500,Early Phase 1,0.12088890049782032,0.8791110995021798
O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,_NICLOSAMIDE,FAMILIAL ADENOMATOUS POLYPOSIS,NCT04296851,Phase 2,0.14868566831779434,0.8513143316822055
OC[C@H]1O[C@H](O[C@]2(CO[C@]3(CO[C@]4(CO[C@]5(CO[C@]6(CO[C@]7(CO[C@]8(CO[C@]9(CO[C@]%10(CO[C@]%11(CO[C@]%12(CO[C@]%13(CO[C@]%14(CO[C@]%15(CO[C@]%16(CO[C@]%17(CO[C@]%18(CO[C@]%19(CO[C@]%20(CO[C@]%21(CO[C@]%22(CO[C@]%23(CO[C@]%24(CO[C@]%25(CO[C@]%26(CO[C@]%27(CO[C@]%28(CO[C@]%29(CO[C@]%30(CO[C@]%31(CO[C@]%32(CO[C@]%33(CO[C@]%34(CO[C@]%35(CO[C@]%36(CO[C@]%37(CO[C@]%38(CO)O[C@H](CO)[C@@H](O)[C@@H]%38O)O[C@H](CO)[C@@H](O)[C@@H]%37O)O[C@H](CO)[C@@H](O)[C@@H]%36O)O[C@H](CO)[C@@H](O)[C@@H]%35O)O[C@H](CO)[C@@H](O)[C@@H]%34O)O[C@H](CO)[C@@H](O)[C@@H]%33O)O[C@H](CO)[C@@H](O)[C@@H]%32O)O[C@H](CO)[C@@H](O)[C@@H]%31O)O[C@H](CO)[C@@H](O)[C@@H]%30O)O[C@H](CO)[C@@H](O)[C@@H]%29O)O[C@H](CO)[C@@H](O)[C@@H]%28O)O[C@H](CO)[C@@H](O)[C@@H]%27O)O[C@H](CO)[C@@H](O)[C@@H]%26O)O[C@H](CO)[C@@H](O)[C@@H]%25O)O[C@H](CO)[C@@H](O)[C@@H]%24O)O[C@H](CO)[C@@H](O)[C@@H]%23O)O[C@H](CO)[C@@H](O)[C@@H]%22O)O[C@H](CO)[C@@H](O)[C@@H]%21O)O[C@H](CO)[C@@H](O)[C@@H]%20O)O[C@H](CO)[C@@H](O)[C@@H]%19O)O[C@H](CO)[C@@H](O)[C@@H]%18O)O[C@H](CO)[C@@H](O)[C@@H]%17O)O[C@H](CO)[C@@H](O)[C@@H]%16O)O[C@H](CO)[C@@H](O)[C@@H]%15O)O[C@H](CO)[C@@H](O)[C@@H]%14O)O[C@H](CO)[C@@H](O)[C@@H]%13O)O[C@H](CO)[C@@H](O)[C@@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_INULIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT04459156,Not Applicable,0.2375803608477524,0.7624196391522478
OC[C@H]1O[C@H](O[C@]2(CO[C@]3(CO[C@]4(CO[C@]5(CO[C@]6(CO[C@]7(CO[C@]8(CO[C@]9(CO[C@]%10(CO[C@]%11(CO[C@]%12(CO[C@]%13(CO[C@]%14(CO[C@]%15(CO[C@]%16(CO[C@]%17(CO[C@]%18(CO[C@]%19(CO[C@]%20(CO[C@]%21(CO[C@]%22(CO[C@]%23(CO[C@]%24(CO[C@]%25(CO[C@]%26(CO[C@]%27(CO[C@]%28(CO[C@]%29(CO[C@]%30(CO[C@]%31(CO[C@]%32(CO[C@]%33(CO[C@]%34(CO[C@]%35(CO[C@]%36(CO[C@]%37(CO[C@]%38(CO)O[C@H](CO)[C@@H](O)[C@@H]%38O)O[C@H](CO)[C@@H](O)[C@@H]%37O)O[C@H](CO)[C@@H](O)[C@@H]%36O)O[C@H](CO)[C@@H](O)[C@@H]%35O)O[C@H](CO)[C@@H](O)[C@@H]%34O)O[C@H](CO)[C@@H](O)[C@@H]%33O)O[C@H](CO)[C@@H](O)[C@@H]%32O)O[C@H](CO)[C@@H](O)[C@@H]%31O)O[C@H](CO)[C@@H](O)[C@@H]%30O)O[C@H](CO)[C@@H](O)[C@@H]%29O)O[C@H](CO)[C@@H](O)[C@@H]%28O)O[C@H](CO)[C@@H](O)[C@@H]%27O)O[C@H](CO)[C@@H](O)[C@@H]%26O)O[C@H](CO)[C@@H](O)[C@@H]%25O)O[C@H](CO)[C@@H](O)[C@@H]%24O)O[C@H](CO)[C@@H](O)[C@@H]%23O)O[C@H](CO)[C@@H](O)[C@@H]%22O)O[C@H](CO)[C@@H](O)[C@@H]%21O)O[C@H](CO)[C@@H](O)[C@@H]%20O)O[C@H](CO)[C@@H](O)[C@@H]%19O)O[C@H](CO)[C@@H](O)[C@@H]%18O)O[C@H](CO)[C@@H](O)[C@@H]%17O)O[C@H](CO)[C@@H](O)[C@@H]%16O)O[C@H](CO)[C@@H](O)[C@@H]%15O)O[C@H](CO)[C@@H](O)[C@@H]%14O)O[C@H](CO)[C@@H](O)[C@@H]%13O)O[C@H](CO)[C@@H](O)[C@@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_INULIN,INFLAMMATORY BOWEL DISEASES,NCT03653481,Not Applicable,0.224403877729502,0.7755961222704978
C=CCN.ClCC1CO1,_SEVELAMER,HYPERPHOSPHATEMIA,NCT04551300,Phase 2,0.10365488640650083,0.8963451135934993
C=CC[NH3+].ClCC1CO1.O=C([O-])O,_SEVELAMER_CARBONATE,HYPERPHOSPHATEMIA,NCT04551300,Phase 2,0.23968114355828396,0.7603188564417159
CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,_LOPERAMIDE,COLORECTAL CANCER METASTATIC,NCT03705442,Phase 2,0.08326152092152528,0.9167384790784748
CCCCCCOC(=O)/N=C(/N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,_DABIGATRAN_ETEXILATE,ACUTE PANCREATITIS,NCT03807856,Phase 1,0.21130629487671534,0.7886937051232847
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,HEPATOCELLULAR CARCINOMA,NCT04258566,Phase 1,0.3646906964017899,0.6353093035982103
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,RHEUMATOID ARTHRITIS,NCT02680067,Phase 1,0.382580655584502,0.6174193444154983
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,ENDOMETRIOSIS,NCT03950206,Not Applicable,0.1465826552223261,0.8534173447776738
C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],_GLYCOPYRROLATE,BURN,NCT03513406,Phase 3,0.14209999882750413,0.8579000011724959
C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],_GLYCOPYRROLATE,CRITICAL ILLNESS,NCT03791801,Not Applicable,0.11648275718225985,0.8835172428177402
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,_TICAGRELOR,CRITICAL ILLNESS,NCT02285751,Phase 2,0.022193856400795228,0.9778061435992048
CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2,_PRASUGREL,CRITICAL ILLNESS,NCT02285751,Phase 2,0.06113036999931753,0.9388696300006824
COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2,_BERBERINE,METABOLIC SYNDROME,NCT03976336,Not Applicable,0.07588546478814212,0.9241145352118578
COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,_DONEPEZIL,"DIABETES MELLITUS, TYPE 2",NCT04507438,Phase 2,0.13409235876954193,0.865907641230458
NCCS.O=C(O)C(O)C(O)C(=O)O,_CYSTEAMINE_BITARTRATE,ASTHMA,NCT03883984,Phase 1,0.3176139707508453,0.6823860292491549
CC(=O)C(=O)O,_PYRUVATE,PROSTATE CANCER,NCT02913131,Phase 1|Phase 2,0.6223471348212346,0.3776528651787647
CC(=O)C(=O)O,_PYRUVATE,BREAST CANCER,NCT03121989,Phase 1,0.33648244024545754,0.6635175597545425
C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1,_PACRITINIB,BREAST CANCER,NCT04520269,Phase 1|Phase 2,0.5609837194895277,0.4390162805104722
CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2,_GRANISETRON,SEPSIS,NCT03924518,Phase 2,0.04111880543089872,0.9588811945691014
CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,_KETOTIFEN,FUNCTIONAL DYSPEPSIA,NCT02484248,Phase 3,0.253427385344702,0.7465726146552981
C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,_LEVOSIMENDAN,ACUTE DECOMPENSATED HEART FAILURE,NCT04158674,Phase 3,0.1523899047648785,0.8476100952351218
Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,_OXYMETAZOLINE,FECAL INCONTINENCE,NCT03529487,Phase 1,0.22234442370471585,0.7776555762952841
O=C(O)c1ccnc(N2CC(O)(c3ccc(OCc4c(-c5c(Cl)cccc5Cl)noc4C4CC4)cc3Cl)C2)c1,_CILOFEXOR,PRIMARY SCLEROSING CHOLANGITIS,NCT03890120,Phase 3,0.8622256329686872,0.13777436703131274
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,_NORFLOXACIN,SPONTANEOUS BACTERIAL PERITONITIS,NCT04161768,Phase 3,0.04873329550431452,0.9512667044956854
CCOC(=O)c1ccc(N)cc1,_BENZOCAINE,OBESITY,NCT02537314,Phase 1,0.190815713348522,0.8091842866514779
Nc1ccc2cc3ccc(N)cc3nc2c1,_PROFLAVINE,BARRETT'S ESOPHAGUS,NCT02018367,Phase 2,0.6890914054201583,0.31090859457984105
CN(C)CCC=C1c2ccccc2COc2ccccc21,_DOXEPIN,BREAST CANCER,NCT02447211,Phase 2,0.2358448427561331,0.7641551572438668
N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,_VILDAGLIPTIN,MAJOR DEPRESSIVE DISORDER,NCT04410341,Phase 1|Phase 2,0.0036862984436985048,0.9963137015563016
O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,_DOMPERIDONE,GASTROPARESIS,NCT03810287,Early Phase 1,0.3250128925040086,0.6749871074959916
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,_PIMAVANSERIN,SCHIZOPHRENIA,NCT04531982,Phase 3,0.2868065098172689,0.7131934901827313
Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,_TOMIVOSERTIB,BREAST CANCER,NCT04261218,Phase 1,0.4956969184162922,0.5043030815837076
CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,_FRUQUINTINIB,METASTATIC COLORECTAL CANCER,NCT03977090,Phase 1,0.3687888457775814,0.6312111542224188
CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,_FRUQUINTINIB,COLORECTAL CANCER,NCT04431791,,0.3198689754767912,0.6801310245232091
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,_QUERCETIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT03989271,Phase 1|Phase 2,0.5552632087626199,0.44473679123738
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,_QUERCETIN,ALZHEIMER DISEASE,NCT04063124,Phase 1|Phase 2,0.5374585842180845,0.4625414157819154
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,_QUERCETIN,CHRONIC KIDNEY DISEASE,NCT02848131,Phase 2,0.4814359181667418,0.5185640818332581
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,_SEMAGLUTIDE,TYPE 1 DIABETES,NCT03899402,Phase 2|Phase 3,0.05085292936050182,0.9491470706394984
O=C(Oc1ccccc1C(=O)O)c1ccccc1O,_SALSALATE,PCOS,NCT03229408,Phase 2,0.15654667872349445,0.8434533212765056
O=C(Oc1ccccc1C(=O)O)c1ccccc1O,_SALSALATE,PREECLAMPSIA,NCT03482440,Early Phase 1,0.15958654292349744,0.8404134570765025
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,PAIN,NCT04313179,Not Applicable,0.14926929719896678,0.8507307028010331
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,IRON DEFICIENCY ANEMIA TREATMENT,NCT03610230,Not Applicable,0.04087725747302635,0.9591227425269736
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,"ANEMIA, IRON DEFICIENCY",NCT03917394,,0.2984159019531758,0.7015840980468243
O.O.O.OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Na+].[Na+].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[OH-],_IRON_SUCROSE,IRON DEFICIENCY ANEMIA TREATMENT,NCT03610230,Not Applicable,0.059093042061211826,0.9409069579387882
O.O.O.OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Na+].[Na+].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[OH-],_IRON_SUCROSE,"ANEMIA, IRON DEFICIENCY",NCT03917394,,0.2513788098979257,0.7486211901020744
O=C([O-])/C=C/C(=O)[O-].[Fe+2],_FERROUS_FUMARATE,"ANEMIA, IRON-DEFICIENCY",NCT04163406,Not Applicable,0.07422965334047882,0.9257703466595212
OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_SORBITOL,NON-ALCOHOLIC FATTY LIVER DISEASE,NCT04330326,Phase 2,0.20462842030204748,0.7953715796979527
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,_GENISTEIN,ALZHEIMER DISEASE,NCT01982578,Not Applicable,0.3775942152380065,0.6224057847619935
Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,_RESVERATROL,"DIABETES MELLITUS, TYPE 1",NCT03436992,Not Applicable,0.23205150923928725,0.767948490760713
Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,_RESVERATROL,FRIEDREICH ATAXIA,NCT03933163,Phase 2,0.026942224616362927,0.9730577753836372
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,PAIN,NCT04132609,Not Applicable,0.44145075065828576,0.5585492493417142
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,MAJOR DEPRESSIVE DISORDER,NCT04137367,Not Applicable,0.13973513913853475,0.8602648608614654
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,OBSTRUCTIVE SLEEP APNEA,NCT02666781,,0.4323290335096264,0.5676709664903735
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,NICOTINE DEPENDENCE,NCT03325777,Not Applicable,0.4155392890328279,0.5844607109671721
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O,_GLUCAGON,INSULIN SECRETION,NCT04347252,Phase 1,0.16288212958422385,0.8371178704157761
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O,_GLUCAGON,INSULIN SENSITIVITY,NCT04300049,Not Applicable,0.2848180810197263,0.7151819189802738
CCCCCCCC/C=C/CCCCCCCC(=O)O,_OLEIC_ACID,CYSTIC FIBROSIS,NCT04531410,Not Applicable,0.3229171143401871,0.6770828856598132
CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,_LINOLEIC_ACID,CYSTIC FIBROSIS,NCT04531410,Not Applicable,0.2511360822966143,0.7488639177033859
OC[C@H](O)[C@H](O)CO,_ERYTHRITOL,OBESITY,NCT02821923,Not Applicable,0.1415409292126142,0.8584590707873859
OC[C@H](O)[C@H](O)CO,_ERYTHRITOL,PERIODONTITIS,NCT04178291,Not Applicable,0.14675859808731273,0.8532414019126874
OC[C@H](O)[C@H](O)CO,_E968,OBESITY,NCT02821923,Not Applicable,0.1415409292126142,0.8584590707873859
OC[C@H](O)[C@H](O)CO,_E968,PERIODONTITIS,NCT04178291,Not Applicable,0.14675859808731273,0.8532414019126874
COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,_HESPERIDIN,METABOLIC SYNDROME,NCT03734874,Not Applicable,0.1710855818967535,0.8289144181032465
COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O,_HESPERIDIN,NON ALCOHOLIC STEATOHEPATITIS,NCT03734510,Not Applicable,0.1710855818967535,0.8289144181032465
Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1,_DEXLANSOPRAZOLE,GASTRO ESOPHAGEAL REFLUX,NCT03202537,Early Phase 1,0.19569468993319175,0.8043053100668083
CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O,_OBETICHOLIC_ACID,OBESITY,NCT02532335,Phase 1,0.12721530039514387,0.8727846996048563
CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O,_OBETICHOLIC_ACID,NON-ALCOHOLIC FATTY LIVER DISEASE,NCT03836937,Not Applicable,0.12721530039514387,0.8727846996048563
C[N@+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_METHYLNALTREXONE,PANCREATIC CANCER,NCT04083651,Phase 2|Phase 3,0.2578092448679656,0.7421907551320345
C[N@+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_METHYLNALTREXONE,POSTOPERATIVE ILEUS,NCT03852524,Phase 2,0.19367089441143726,0.8063291055885631
O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,_FASUDIL,AMYOTROPHIC LATERAL SCLEROSIS,NCT03792490,Phase 2,0.1640425902303662,0.8359574097696341
CC(=O)N[C@@H]1C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC2[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)[C@H](O)[C@H]1O,_HYALURONIC_ACID,"PAIN, POSTOPERATIVE",NCT03814707,Not Applicable,0.17430984719399462,0.8256901528060056
CC(=O)N[C@@H]1C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC2[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)[C@H](O)[C@H]1O,_HYALURONIC_ACID,GASTRO ESOPHAGEAL REFLUX,NCT04202692,Not Applicable,0.4173128759332957,0.5826871240667044
O=[Si]([O-])O[Si]([O-])([O-])O[Si](=O)[O-].[Mg+2].[Mg+2],_MAGNESIUM_TRISILICATE,GASTRO ESOPHAGEAL REFLUX,NCT04202692,Not Applicable,0.3415785294057501,0.6584214705942502
O=[O+][O-],_OZONE,ISCHEMIC HEART DISEASE,NCT03660657,Phase 2|Phase 3,0.08708942732300995,0.91291057267699
Cc1c(O)c(=O)ccn1C,_DEFERIPRONE,AMYOTROPHIC LATERAL SCLEROSIS,NCT03293069,Phase 2|Phase 3,0.04133738512391098,0.9586626148760891
CC/C=C/CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)CC)C(C)C)C(C)O)C(C)CC,_TESAMORELIN,MILD COGNITIVE IMPAIRMENT,NCT02572323,Phase 2,0.16118777824475036,0.8388122217552498
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,_FLUTICASONE_FUROATE,PHARMACOKINETICS,NCT03739294,Phase 2,0.17103804046242793,0.8289619595375722
Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,_CANAGLIFLOZIN,HEART FAILURE,NCT04252287,Phase 3,0.06428709695865747,0.9357129030413424
Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1,_SUVOREXANT,NICOTINE DEPENDENCE,NCT03999099,Phase 1,0.19545996165931226,0.8045400383406879
COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,_ELUXADOLINE,IRRITABLE BOWEL SYNDROME,NCT03339128,Phase 2,0.3197693494962664,0.6802306505037339
OC[C@H](O)[C@@H](O)[C@H](O)CO,_XYLITOL,END STAGE RENAL DISEASE,NCT04001036,Phase 2,0.2572428427209747,0.7427571572790255
O=C(O)c1cc(O)c2c(c1)C(C1c3cc(C(=O)O)cc(O)c3C(=O)c3c(OC4OC(CO)C(O)C(O)C4O)cccc31)c1cccc(OC3OC(CO)C(O)C(O)C3O)c1C2=O,_SENNOSIDES,COLON CANCER,NCT03475680,Phase 3,0.2364288949784245,0.7635711050215757
NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,_CARNOSINE,SCHIZOPHRENIA,NCT02686697,Phase 2|Phase 3,0.2351747033935973,0.7648252966064026
NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O,_L-CARNOSINE,SCHIZOPHRENIA,NCT02686697,Phase 2|Phase 3,0.2351747033935973,0.7648252966064026
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O,_ANGIOTENSIN_1-7,PERIPHERAL ARTERIAL DISEASE,NCT03240068,Early Phase 1,0.4478385703690991,0.5521614296309011
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O,_TXA127,PERIPHERAL ARTERIAL DISEASE,NCT03240068,Early Phase 1,0.4478385703690991,0.5521614296309011
Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,_BRIVANIB,OVARIAN CANCER,NCT03895788,Phase 1,0.4781044339460248,0.5218955660539752
Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1,_ANAGLIPTIN,TYPE 2 DIABETES,NCT04267601,,0.3439692713074441,0.6560307286925561
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,_RACLOPRIDE,MAJOR DEPRESSIVE DISORDER,NCT03026036,,0.5080013734652626,0.4919986265347374
O=N[O-],_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.3436329593437095,0.6563670406562909
NC(=O)C1(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2csc3ccccc23)NC(=O)C2CCNCC2)CCNCC1,_RELAMORELIN,GASTROPARESIS|DIABETES MELLITUS,NCT03420781,Phase 3,0.6442334322266922,0.3557665677733076
CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O,_ETELCALCETIDE,END STAGE RENAL DISEASE,NCT03795558,Phase 2,0.4804064357951049,0.5195935642048952
CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O,_ETELCALCETIDE,SECONDARY HYPERPARATHYROIDISM|CHRONIC KIDNEY DISEASE,NCT03633708,Phase 3,0.4459597772998503,0.5540402227001497
Nc1ncc2ncn(CC3(OCP(=O)(O)O)CC3)c2n1,_BESIFOVIR,CHRONIC HEPATITIS B,NCT02792088,Phase 3,0.08211347463881022,0.91788652536119
CCCCCCCCCCCCCCCC(=O)NCC(O)COP(=O)(S)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1NP(=O)(S)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2ccc(N)nc2=O)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1N,_IMETELSTAT,MYELODYSPLASTIC SYNDROME,NCT02598661,Phase 2|Phase 3,0.5538067029269891,0.4461932970730109
C[C@@H](N)[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1O,_ELX-02,CYSTIC FIBROSIS,NCT04135495,Phase 2,0.7071428248492687,0.2928571751507312
O=C1/C(=C2\Nc3ccccc3C2=O)Nc2ccccc21,_INDIGO,COLONOSCOPY,NCT03250780,Not Applicable,0.33286141038322564,0.6671385896167747
Oc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2,_CATECHIN,CIRRHOSIS,NCT03278925,Phase 1,0.623959439615967,0.3760405603840329
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C,_SECRETIN,PANCREATIC CANCER,NCT03404661,,0.3438331298214567,0.6561668701785434
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C,_SECRETIN,"PANCREATITIS, ACUTE",NCT03686618,Phase 2,0.2464712469076905,0.7535287530923095
O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,_MORIN,METABOLIC SYNDROME,NCT04314258,Not Applicable,0.14991874994803414,0.8500812500519657
CCCCCC1=CC(=O)C=C(OC)C1=O,_PRIMIN,STROKE,NCT03517657,Not Applicable,0.28640223774654905,0.7135977622534512
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC,_TEDUGLUTIDE,HYPERLIPIDEMIA,NCT03442972,Phase 2|Phase 3,0.07642063738101113,0.9235793626189888
NC(=O)OCC(COC(N)=O)c1ccccc1,_FELBAMATE,EPILEPSY,NCT03196466,,0.2727418603611137,0.7272581396388863
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C,_DEOXYCHOLIC_ACID,ADIPOSITY,NCT04054011,Early Phase 1,0.4576163940053909,0.542383605994609
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,_CARIPRAZINE,MAJOR DEPRESSIVE DISORDER,NCT03739203,Phase 3,0.4194037556815376,0.5805962443184625
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,_CARIPRAZINE,SCHIZOPHRENIA,NCT03817502,Phase 3,0.4125173987868511,0.5874826012131489
N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,_TIPIRACIL,COLORECTAL CANCER,NCT03974594,Phase 1,0.28388058661011617,0.716119413389884
CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,_LASMIDITAN,MIGRAINE DISORDERS,NCT04396574,Phase 3,0.3998174955852094,0.6001825044147908
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,_ALPELISIB,BREAST CANCER,NCT03056755,Phase 2,0.5682883034301675,0.4317116965698325
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N,_OZANIMOD,CROHN'S DISEASE,NCT03467958,Phase 3,0.3972421384613827,0.6027578615386174
CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N,_OZANIMOD,"COLITIS, ULCERATIVE",NCT03915769,Phase 3,0.3990754001534128,0.6009245998465874
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,_DAROLUTAMIDE,PROSTATE CANCER,NCT04136353,Phase 3,0.248112965817996,0.7518870341820042
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,CROHN'S DISEASE,NCT03345849,Phase 3,0.4234370751837551,0.5765629248162449
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT04451772,Phase 2,0.42484495917786014,0.57515504082214
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SPONDYLOARTHRITIS,NCT04169373,Phase 3,0.4234370751837551,0.5765629248162449
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ULCERATIVE COLITIS,NCT03006068,Phase 3,0.4380323026137967,0.5619676973862033
C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,_UBROGEPANT,MIGRAINE DISORDERS,NCT04492020,Phase 3,0.4413403619190279,0.5586596380809722
